Kovack Advisors’s Johnson & Johnson JNJ Stock Holding History

Kovack Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.11M	Sell	20,128 -1,912	-9%	-$446K	0.25%	82
2026 Q1	$5.38M	Sell	22,040 -14,086	-39%	-$3.28M	0.29%	71
2025 Q4	$7.48M	Buy	36,126 +10,459	+41%	+$2.07M	0.35%	62
2025 Q3	$4.76M	Sell	25,667 -5,055	-16%	-$866K	0.45%	44
2025 Q2	$4.69M	Buy	30,722 +478	+2%	+$73.5K	0.46%	42
2025 Q1	$5.02M	Sell	30,244 -517	-2%	-$80.9K	0.53%	38
2024 Q4	$4.45M	Buy	30,761 +88	+0.3%	+$13.6K	0.44%	43
2024 Q3	$4.97M	Sell	30,673 -2,315	-7%	-$369K	0.53%	38
2024 Q2	$4.82M	Buy	32,988 +947	+3%	+$141K	0.53%	34
2024 Q1	$5.07M	Buy	32,041 +2,759	+9%	+$439K	0.61%	30
2023 Q4	$4.59M	Buy	29,282 +2,231	+8%	+$342K	0.55%	28
2023 Q3	$4.21M	Buy	27,051 +2,772	+11%	+$457K	0.59%	26
2023 Q2	$4.02M	Buy	24,279 +6,587	+37%	+$1.06M	0.51%	33
2023 Q1	$2.74M	Sell	17,692 -222	-1%	-$35.8K	0.37%	55
2022 Q4	$3.16M	Sell	17,914 -2,194	-11%	-$379K	0.46%	40
2022 Q3	$3.29M	Sell	20,108 -529	-3%	-$89.5K	0.48%	36
2022 Q2	$3.66M	Sell	20,637 -4,112	-17%	-$733K	0.48%	33
2022 Q1	$4.39M	Buy	24,749 +1,551	+7%	+$264K	0.45%	37
2021 Q4	$3.97M	Sell	23,198 -478	-2%	-$78.3K	0.38%	46
2021 Q3	$3.82M	Sell	23,676 -320	-1%	-$54.6K	0.42%	44
2021 Q2	$3.95M	Sell	23,996 -1,089	-4%	-$180K	0.45%	43
2021 Q1	$4.12M	Buy	25,085 +246	+1%	+$39.8K	0.54%	32
2020 Q4	$3.91M	Buy	24,839 +449	+2%	+$66.3K	0.56%	28
2020 Q3	$3.63M	Buy	24,390 +1,002	+4%	+$148K	0.65%	27
2020 Q2	$3.29M	Sell	23,388 -1,932	-8%	-$282K	0.64%	27
2020 Q1	$3.32M	Sell	25,320 -766	-3%	-$109K	0.77%	21
2019 Q4	$3.81M	Buy	26,086 +1,079	+4%	+$146K	0.68%	21
2019 Q3	$3.23M	Sell	25,007 -1,798	-7%	-$237K	0.66%	25
2019 Q2	$3.73M	Sell	26,805 -753	-3%	-$104K	0.85%	18
2019 Q1	$3.85M	Buy	27,558 +868	+3%	+$116K	0.96%	15
2018 Q4	$3.44M	Buy	26,690 +723	+3%	+$101K	1.01%	15
2018 Q3	$3.59M	Buy	25,967 +1,940	+8%	+$258K	0.93%	15
2018 Q2	$2.92M	Sell	24,027 -7,033	-23%	-$877K	0.81%	16
2018 Q1	$3.98M	Buy	31,060 +256	+0.8%	+$34.6K	1%	15
2017 Q4	$4.26M	Buy	30,804 +6,368	+26%	+$887K	1.08%	13
2017 Q3	$3.18M	Sell	24,436 -190	-0.8%	-$25.2K	1.05%	15
2017 Q2	$3.26M	Buy	24,626 +3,355	+16%	+$428K	1.03%	14
2017 Q1	$2.65M	Buy	21,271 +3,157	+17%	+$377K	1.03%	15
2016 Q4	$2.09M	Sell	18,114 -2,237	-11%	-$258K	0.99%	18
2016 Q3	$2.4M	Buy	20,351 +6,765	+50%	+$821K	1.17%	16
2016 Q2	$1.65M	Buy	13,586 +219	+2%	+$24.9K	0.87%	23
2016 Q1	$1.45M	Buy	13,367 +1,228	+10%	+$127K	0.9%	25
2015 Q4	$1.25M	Sell	12,139 -769	-6%	-$77.3K	0.82%	29
2015 Q3	$1.21M	Buy	12,908 +2,074	+19%	+$201K	0.84%	26
2015 Q2	$1.06M	Buy	10,834 +1,749	+19%	+$175K	0.75%	33
2015 Q1	$914K	Buy	9,085 +1,627	+22%	+$165K	0.77%	30
2014 Q4	$780K	Buy	7,458 +4,823	+183%	+$508K	0.81%	26
2014 Q3	$281K	Buy	2,635 +413	+19%	+$42.8K	0.41%	55
2014 Q2	$232K	Buy	+2,222	New	+$225K	0.34%	71
2014 Q1	–	Sell	-2,389	Closed	-$219K	–	86
2013 Q4	$219K	Sell	2,389 -11	-0.5%	-$1.01K	1.19%	37
2013 Q3	$208K	Buy	+2,400	New	+$215K	1.07%	38

Other funds holding JNJ

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

AACR

ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Kovack Advisors's JNJ Position: Q2 2026 in Review

Kovack Advisors reduced its Johnson & Johnson (JNJ) stake by 8.7% in Q2 2026, selling an estimated $446K and leaving 20,128 shares worth $5.11M. The position accounts for 0.25% of the portfolio, ranked #82.

Kovack Advisors first reported a position in JNJ in Q3 2013 and has held it in 51 quarters since. The position peaked at $7.48M in Q4 2025. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Kovack Advisors held 20,128 shares of Johnson & Johnson worth $5.11M as of Q2 2026.
Kovack Advisors sold 1,912 Johnson & Johnson shares in Q2 2026, an estimated $446K.
Johnson & Johnson made up 0.25% of Kovack Advisors's portfolio in Q2 2026, its #82 holding.
Kovack Advisors first reported a position in Johnson & Johnson in Q3 2013 and has held it in 51 quarters since.
Kovack Advisors's Johnson & Johnson position peaked at $7.48M in Q4 2025.
2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Kovack Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.